Belite Bio, Inc (BLTE) stock
BLTENasdaqPharmaceutical PreparationsFiscal year ends December 31
$156.23−1.49 (-0.94%)
Close on Nov 18, 2026Market cap $6.15BP/E –Yield –
Belite Bio free cash flow
Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.
For fiscal 2025 it was -$37.06M. The highest annual figure on record is -$7.55M in fiscal 2021.
Annual free cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$37.06M | – |
| FY2024 | Dec 31, 2024 | -$29.35M | – |
| FY2023 | Dec 31, 2023 | -$29.90M | – |
| FY2022 | Dec 31, 2022 | -$11.85M | – |
| FY2021 | Dec 31, 2021 | -$7.55M | – |
See a number that looks wrong?